156 related articles for article (PubMed ID: 37928269)
1. FLOT1 promotes gastric cancer progression and metastasis through BCAR1/ERK signaling.
Wang R; Huang W; Cai K; Xiao S; Zhang W; Hu X; Guo J; Mao L; Yuan W; Xu Y; Chen Z; Chen Z; Lai C
Int J Biol Sci; 2023; 19(16):5104-5119. PubMed ID: 37928269
[TBL] [Abstract][Full Text] [Related]
2. Flotillin-1 promotes tumor necrosis factor-α receptor signaling and activation of NF-κB in esophageal squamous cell carcinoma cells.
Song L; Gong H; Lin C; Wang C; Liu L; Wu J; Li M; Li J
Gastroenterology; 2012 Oct; 143(4):995-1005.e12. PubMed ID: 22732732
[TBL] [Abstract][Full Text] [Related]
3. FLOT1 promotes tumor development, induces epithelial-mesenchymal transition, and modulates the cell cycle by regulating the Erk/Akt signaling pathway in lung adenocarcinoma.
Zhang L; Mao Y; Mao Q; Fan W; Xu L; Chen Y; Xu L; Wang J
Thorac Cancer; 2019 Apr; 10(4):909-917. PubMed ID: 30838797
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of flotillin-1 promotes invasion and metastasis by activating TGF-β signaling in nasopharyngeal carcinoma.
Cao S; Cui Y; Xiao H; Mai M; Wang C; Xie S; Yang J; Wu S; Li J; Song L; Guo X; Lin C
Oncotarget; 2016 Jan; 7(4):4252-64. PubMed ID: 26646322
[TBL] [Abstract][Full Text] [Related]
5. Association of the breast cancer antiestrogen resistance protein 1 (BCAR1) and BCAR3 scaffolding proteins in cell signaling and antiestrogen resistance.
Wallez Y; Riedl SJ; Pasquale EB
J Biol Chem; 2014 Apr; 289(15):10431-10444. PubMed ID: 24584939
[TBL] [Abstract][Full Text] [Related]
6. Flotillin-1 is a prognostic biomarker for glioblastoma and promotes cancer development through enhancing invasion and altering tumour microenvironment.
Wang R; Chen Z; Zhang Y; Xiao S; Zhang W; Hu X; Xiao Q; Liu Q; Wang X
J Cell Mol Med; 2023 Feb; 27(3):392-402. PubMed ID: 36647700
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen treatment promotes phosphorylation of the adhesion molecules, p130Cas/BCAR1, FAK and Src, via an adhesion-dependent pathway.
Cowell LN; Graham JD; Bouton AH; Clarke CL; O'Neill GM
Oncogene; 2006 Dec; 25(58):7597-607. PubMed ID: 16799644
[TBL] [Abstract][Full Text] [Related]
8. Mutant TP53 interacts with BCAR1 to contribute to cancer cell invasion.
Guo AK; Itahana Y; Seshachalam VP; Chow HY; Ghosh S; Itahana K
Br J Cancer; 2021 Jan; 124(1):299-312. PubMed ID: 33144694
[TBL] [Abstract][Full Text] [Related]
9. Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer.
Li L; Luo J; Wang B; Wang D; Xie X; Yuan L; Guo J; Xi S; Gao J; Lin X; Kong Y; Xu X; Tang H; Xie X; Liu M
Mol Cancer; 2013 Dec; 12():163. PubMed ID: 24330780
[TBL] [Abstract][Full Text] [Related]
10. High Expression of FLOT1 Is Associated with Progression and Poor Prognosis in Hepatocellular Carcinoma.
Zhang SH; Wang CJ; Shi L; Li XH; Zhou J; Song LB; Liao WT
PLoS One; 2013; 8(6):e64709. PubMed ID: 23840303
[TBL] [Abstract][Full Text] [Related]
11. Drug-resistance reversal in colorectal cancer cells by destruction of flotillins, the key lipid rafts proteins.
Ye DM; Ye SC; Yu SQ; Shu FF; Xu SS; Chen QQ; Wang YL; Tang ZT; Pan C
Neoplasma; 2019 Jul; 66(4):576-583. PubMed ID: 30943747
[TBL] [Abstract][Full Text] [Related]
12. BCAR1 promotes proliferation and cell growth in lung adenocarcinoma via upregulation of POLR2A.
Mao CG; Jiang SS; Shen C; Long T; Jin H; Tan QY; Deng B
Thorac Cancer; 2020 Nov; 11(11):3326-3336. PubMed ID: 33001583
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA A1BG-AS1 promotes tumorigenesis in breast cancer by sponging microRNA-485-5p and consequently increasing expression of FLOT1 expression.
Cai S; Zhou Y; Pan Y; Liu P; Yu K; Chen S
Hum Cell; 2021 Sep; 34(5):1517-1531. PubMed ID: 34115333
[TBL] [Abstract][Full Text] [Related]
14. BCAR1 protein plays important roles in carcinogenesis and predicts poor prognosis in non-small-cell lung cancer.
Huang W; Deng B; Wang RW; Tan QY; He Y; Jiang YG; Zhou JH
PLoS One; 2012; 7(4):e36124. PubMed ID: 22558353
[TBL] [Abstract][Full Text] [Related]
15. Flotillin-1 expression in human clear-cell renal cell carcinoma is associated with cancer progression and poor patient survival.
Zhang Y; Li J; Song Y; Chen F; Pei Y; Yao F
Mol Med Rep; 2014 Aug; 10(2):860-6. PubMed ID: 24913320
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of FLOT1 impairs cell proliferation and tumorigenicity in breast cancer through upregulation of FOXO3a.
Lin C; Wu Z; Lin X; Yu C; Shi T; Zeng Y; Wang X; Li J; Song L
Clin Cancer Res; 2011 May; 17(10):3089-99. PubMed ID: 21447726
[TBL] [Abstract][Full Text] [Related]
17. Flotillin-1 promotes EMT of gastric cancer
Huang Y; Guo Y; Xu Y; Liu F; Dai S
PeerJ; 2022; 10():e13901. PubMed ID: 35990908
[TBL] [Abstract][Full Text] [Related]
18. Identification of Novel Crk-associated Substrate (p130Cas) Variants with Functionally Distinct Focal Adhesion Kinase Binding Activities.
Kumbrink J; Soni S; Laumbacher B; Loesch B; Kirsch KH
J Biol Chem; 2015 May; 290(19):12247-55. PubMed ID: 25805500
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-6809-5p mediates luteolin-induced anticancer effects against hepatoma by targeting flotillin 1.
Yang PW; Lu ZY; Pan Q; Chen TT; Feng XJ; Wang SM; Pan YC; Zhu MH; Zhang SH
Phytomedicine; 2019 Apr; 57():18-29. PubMed ID: 30668319
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of flotillin-1 is involved in proliferation and recurrence of bladder transitional cell carcinoma.
Guan Y; Song H; Zhang G; Ai X
Oncol Rep; 2014 Aug; 32(2):748-54. PubMed ID: 24890092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
